Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts Inc (NQ: TMCI )

11.88 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 372,097
Open 11.92
Bid (Size) 10.96 (1)
Ask (Size) 13.89 (1)
Prev. Close 11.88
Today's Range 11.66 - 11.95
52wk Range 5.270 - 27.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Stable Stocks for 50% Returns by Early 2025
These 7 stable stocks also offer 50% returns according to analysts according to analysts tasked with following their respective industries. 
Via InvestorPlace
Treace to Report First Quarter 2024 Financial Results
Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire

Performance

YTD
-5.41%
-5.41%
1 Month
-1.00%
-1.00%
3 Month
-4.96%
-4.96%
6 Month
+15.56%
+15.56%
1 Year
-54.02%
-54.02%

More News

Read More
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Recap: Treace Medical Concepts Q4 Earnings
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Earnings Preview For Treace Medical Concepts
Via Benzinga
6 Analysts Assess Treace Medical Concepts: What You Need To Know
Via Benzinga
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Analyst Ratings for Treace Medical Concepts
Via Benzinga
The Latest Analyst Ratings for Treace Medical Concepts
Via Benzinga
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Gains Over 100 Points; Wynn Resorts Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Treace Medical Concepts Disappoints On Q3 Results, Lowers FY23 Guidance
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Earnings Scheduled For November 9, 2023
Via Benzinga
Treace to Present at Stifel 2023 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Third Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.